Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imlifidase in Highly Sensitized Living Donor Kidney Transplantation
NCT06461546Phase 2Withdrawn
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Oct 2024
- Primary completion
- Dec 2026
- Modality
- Therapeutic Enzymes
01
Overview
A Phase 2 trial of imlifidase in kidney transplant rejection, sponsored by Fundació Clínic per a la Recerca Biomèdica. Planned start Oct 2024; status: withdrawn.
02
Drugs
imlifidase
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT06461546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06461546.